Strategies for targeting cytokines in inflammatory bowel disease
The DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coombes, J. L., Siddiqui, K. R. R., Arancibia-Cárcamo, C. V., Hall, J., Sun, C.-M., Belkaid, Y., & Powrie, F. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070590 · Cited by 2,710
Cytokines in inflammatory bowel disease
Neurath, M. F. (2014) · Nature Reviews Immunology · doi:10.1038/nri3661 · Cited by 2,706
Self-citationGrivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
Sandborn, W. J., Su, C., Sands, B. E., D’Haens, G. R., Vermeire, S., Schreiber, S., Danese, S., Feagan, B. G., Reinisch, W., Niezychowski, W., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1606910 · Cited by 1,770
Hueber, W., Sands, B. E., Lewitzky, S., Vandemeulebroecke, M., Reinisch, W., Higgins, P. D. R., Wehkamp, J., Feagan, B. G., Yao, M. D., Karczewski, M., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301668 · Cited by 1,547
Treatment of Murine Colitis by Lactococcus lactis Secreting Interleukin-10
Steidler, L., Hans, W., Schotte, L., Neirynck, S., Obermeier, F., Falk, W., Fiers, W., & Remaut, E. (2000) · Science · doi:10.1126/science.289.5483.1352 · Cited by 1,513
Atreya, R., Mudter, J., Finotto, S., Müllberg, J., Jostock, T., Wirtz, S., Schütz, M., Bartsch, B., Holtmann, M., Becker, C., et al. (2000) · Nature Medicine · doi:10.1038/75068 · Cited by 1,293
Self-citationDardalhon, V., Awasthi, A., Kwon, H., Galileos, G., Gao, W., Sobel, R. A., Mitsdoerffer, M., Strom, T. B., Elyaman, W., Ho, I.-C., et al. (2008) · Nature Immunology · doi:10.1038/ni.1677 · Cited by 1,122
Danese, S., & Fiocchi, C. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1102942 · Cited by 1,102
Yang, W., Yu, T., Huang, X., Bilotta, A. J., Xu, L., Lu, Y., Sun, J., Pan, F., Zhou, J., Zhang, W., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18262-6 · Cited by 1,042
The alarmin IL-33 promotes regulatory T-cell function in the intestine
Schiering, C., Krausgruber, T., Chomka, A., Fröhlich, A., Adelmann, K., Wohlfert, E. A., Pott, J., Griseri, T., Bollrath, J., Hegazy, A. N., et al. (2014) · Nature · doi:10.1038/nature13577 · Cited by 1,005
Death by TNF: a road to inflammation
van Loo, G., & Bertrand, M. J. M. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00792-3 · Cited by 926
Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trial
Sandborn, W. J., Hanauer, S. B., Katz, S., Safdi, M., Wolf, D. G., Baerg, R. D., Tremaine, W. J., Johnson, T., Diehl, N. N., & Zinsmeister, A. R. (2001) · Gastroenterology · doi:10.1053/gast.2001.28674 · Cited by 910
Fuchs, A., Vermi, W., Lee, J. S., Lonardi, S., Gilfillan, S., Newberry, R. D., Cella, M., & Colonna, M. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.010 · Cited by 907
Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome
Bauer, C., Duewell, P., Mayer, C., Lehr, H. A., Fitzgerald, K. A., Dauer, M., Tschopp, J., Endres, S., Latz, E., & Schnurr, M. (2010) · Gut · doi:10.1136/gut.2009.197822 · Cited by 906
Oxford IBD Cohort Investigators, West, N. R., Hegazy, A. N., Owens, B. M. J., Bullers, S. J., Linggi, B., Buonocore, S., Coccia, M., Görtz, D., This, S., et al. (2017) · Nature Medicine · doi:10.1038/nm.4307 · Cited by 811
Fuss, I. J., Heller, F., Boirivant, M., Leon, F., Yoshida, M., Fichtner-Feigl, S., Yang, Z., Exley, M., Kitani, A., Blumberg, R. S., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19836 · Cited by 797
Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability
Lee, J. S., Tato, C. M., Joyce-Shaikh, B., Gulen, M. F., Cayatte, C., Chen, Y., Blumenschein, W. M., Judo, M., Ayanoglu, G., McClanahan, T. K., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.09.003 · Cited by 760 · cited 1×
“Additionally, IL-17A was shown to induce expression of the tight junction protein occludin and to promote intestinal barrier integrity in experimental colitis 142 , which may explain the observed worsening of disease activity in individuals with Crohn’s disease who received secukinumab 127 .”
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
Sands, B. E., Peyrin-Biroulet, L., Loftus, E. V., Danese, S., Colombel, J.-F., Törüner, M., Jonaitis, L., Abhyankar, B., Chen, J., Rogers, R., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1905725 · Cited by 754
TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling
Becker, C., Fantini, M. C., Schramm, C., Lehr, H. A., Wirtz, S., Nikolaev, A., Burg, J., Strand, S., Kiesslich, R., Huber, S., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.020 · Cited by 726
Self-citationDifferential Activity of IL-12 and IL-23 in Mucosal and Systemic Innate Immune Pathology
Uhlig, H. H., McKenzie, B. S., Hue, S., Thompson, C., Joyce-Shaikh, B., Stepankova, R., Robinson, N., Buonocore, S., Tlaskalova-Hogenova, H., Cua, D. J., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.05.017 · Cited by 682
IL-33 is a crucial amplifier of innate rather than acquired immunity
Oboki, K., Ohno, T., Kajiwara, N., Arae, K., Morita, H., Ishii, A., Nambu, A., Abe, T., Kiyonari, H., Matsumoto, K., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003059107 · Cited by 652
Heller, F., Fuss, I. J., Nieuwenhuis, E. E., Blumberg, R. S., & Strober, W. (2002) · Immunity · doi:10.1016/s1074-7613(02)00453-3 · Cited by 650
Danese, S., Vermeire, S., Zhou, W., Pangan, A. L., Siffledeen, J., Greenbloom, S., Hébuterne, X., D'Haens, G., Nakase, H., Panés, J., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00581-5 · Cited by 643
Kamada, N., Hisamatsu, T., Okamoto, S., Chinen, H., Kobayashi, T., Sato, T., Sakuraba, A., Kitazume, M. T., Sugita, A., Koganei, K., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34610 · Cited by 603
Coccia, M., Harrison, O. J., Schiering, C., Asquith, M. J., Becher, B., Powrie, F., & Maloy, K. J. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20111453 · Cited by 580
Monteleone, G., Biancone, L., Marasco, R., Morrone, G., Marasco, O., Luzza, F., & Pallone, F. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70128-8 · Cited by 573
Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis
Nowarski, R., Jackson, R., Gagliani, N., de Zoete, M. R., Palm, N. W., Bailis, W., Low, J. S., Harman, C. C. D., Graham, M., Elinav, E., et al. (2015) · Cell · doi:10.1016/j.cell.2015.10.072 · Cited by 558
Zigmond, E., Bernshtein, B., Friedlander, G., Walker, C. R., Yona, S., Kim, K.-W., Brenner, O., Krauthgamer, R., Varol, C., Müller, W., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.03.012 · Cited by 556
Targeting IL-6 trans-signalling: past, present and future prospects
Rose-John, S., Jenkins, B. J., Garbers, C., Moll, J. M., & Scheller, J. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00856-y · Cited by 524
Characterization of Foxp3+CD4+CD25+ and IL-10-Secreting CD4+CD25+ T Cells during Cure of Colitis
Uhlig, H. H., Coombes, J., Mottet, C., Izcue, A., Thompson, C., Fanger, A., Tannapfel, A., Fontenot, J. D., Ramsdell, F., & Powrie, F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.5852 · Cited by 463
Feagan, B. G., Danese, S., Loftus, E. V., Vermeire, S., Schreiber, S., Ritter, T., Fogel, R., Mehta, R., Nijhawan, S., Kempiński, R., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00666-8 · Cited by 462
Toll-like receptor 9–induced type I IFN protects mice from experimental colitis
Katakura, K., Lee, J., Rachmilewitz, D., Li, G., Eckmann, L., & Raz, E. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22996 · Cited by 451
Leppkes, M., Becker, C., Ivanov, I. I., Hirth, S., Wirtz, S., Neufert, C., Pouly, S., Murphy, A. J., Valenzuela, D. M., Yancopoulos, G. D., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.018 · Cited by 444
Self-citationD'Haens, G., Panaccione, R., Baert, F., Bossuyt, P., Colombel, J.-F., Danese, S., Dubinsky, M., Feagan, B. G., Hisamatsu, T., Lim, A., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00467-6 · Cited by 433
IL-1β and the Intestinal Epithelial Tight Junction Barrier
Kaminsky, L. W., Al-Sadi, R., & Ma, T. Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.767456 · Cited by 432
IL-1β-converting enzyme (caspase-1) in intestinal inflammation
Siegmund, B., Lehr, H.-A., Fantuzzi, G., & Dinarello, C. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231473998 · Cited by 421
Mechanism of IL-1β-Induced Increase in Intestinal Epithelial Tight Junction Permeability
Al-Sadi, R., Ye, D., Dokladny, K., & Ma, T. Y. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.8.5653 · Cited by 417
Pastorelli, L., Garg, R. R., Hoang, S. B., Spina, L., Mattioli, B., Scarpa, M., Fiocchi, C., Vecchi, M., & Pizarro, T. T. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912678107 · Cited by 415
Gerlach, K., Hwang, Y., Nikolaev, A., Atreya, R., Dornhoff, H., Steiner, S., Lehr, H.-A., Wirtz, S., Vieth, M., Waisman, A., et al. (2014) · Nature Immunology · doi:10.1038/ni.2920 · Cited by 407
Self-citationMongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn’s Disease
Monteleone, G., Neurath, M. F., Ardizzone, S., Di Sabatino, A., Fantini, M. C., Castiglione, F., Scribano, M. L., Armuzzi, A., Caprioli, F., Sturniolo, G. C., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1407250 · Cited by 401
Self-citationAtreya, R., Neumann, H., Neufert, C., Waldner, M. J., Billmeier, U., Zopf, Y., Willma, M., App, C., Münster, T., Kessler, H., et al. (2014) · Nature Medicine · doi:10.1038/nm.3462 · Cited by 392
Self-citationDesreumaux, P., Foussat, A., Allez, M., Beaugerie, L., Hébuterne, X., Bouhnik, Y., Nachury, M., Brun, V., Bastian, H., Belmonte, N., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.116 · Cited by 384
Reframing Immune-Mediated Inflammatory Diseases through Signature Cytokine Hubs
Schett, G., McInnes, I. B., & Neurath, M. F. (2021) · New England Journal of Medicine · doi:10.1056/nejmra1909094 · Cited by 355
Self-citationDifferential Roles for Interleukin-23 and Interleukin-17 in Intestinal Immunoregulation
Maxwell, J. R., Zhang, Y., Brown, W. A., Smith, C. L., Byrne, F. R., Fiorino, M., Stevens, E., Bigler, J., Davis, J. A., Rottman, J. B., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.08.019 · Cited by 342 · cited 1×
“This is possibly due to impaired IL-17R signalling in IECs with consequent reduced claudin production and impaired barrier stability 127,128 .”
Cytokine-mediated communication: a quantitative appraisal of immune complexity
Altan-Bonnet, G., & Mukherjee, R. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0131-x · Cited by 341
Interleukin 37 expression protects mice from colitis
McNamee, E. N., Masterson, J. C., Jedlicka, P., McManus, M., Grenz, A., Collins, C. B., Nold, M. F., Nold-Petry, C., Bufler, P., Dinarello, C. A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111982108 · Cited by 320
de Luca, A., Smeekens, S. P., Casagrande, A., Iannitti, R., Conway, K. L., Gresnigt, M. S., Begun, J., Plantinga, T. S., Joosten, L. A. B., van der Meer, J. W. M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322831111 · Cited by 313
Wang, F., Schwarz, B. T., Graham, W. V., Wang, Y., Su, L., Clayburgh, D. R., Abraham, C., & Turner, J. R. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.08.022 · Cited by 310
Friedrich, M., Pohin, M., Jackson, M. A., Korsunsky, I., Bullers, S. J., Rue-Albrecht, K., Christoforidou, Z., Sathananthan, D., Thomas, T., Ravindran, R., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01520-5 · Cited by 303
Bamias, G., Martin, C., Marini, M., Hoang, S., Mishina, M., Ross, W. G., Sachedina, M. A., Friel, C. M., Mize, J., Bickston, S. J., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.9.4868 · Cited by 299
Suppression of inflammation and acquired immunity by IL‐37
Cavalli, G., & Dinarello, C. A. (2018) · Immunological Reviews · doi:10.1111/imr.12605 · Cited by 291
Boutet, M.-A., Bart, G., Penhoat, M., Amiaud, J., Brulin, B., Charrier, C., Morel, F., Lecron, J.-C., Rolli-Derkinderen, M., Bourreille, A., et al. (2016) · Clinical and Experimental Immunology · doi:10.1111/cei.12761 · Cited by 275
Th17 plasticity and its relevance to inflammatory bowel disease
Ueno, A., Jeffery, L., Kobayashi, T., Hibi, T., Ghosh, S., & Jijon, H. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.12.004 · Cited by 266
Regulation of Gut Inflammation and Th17 Cell Response by Interleukin-21
Fina, D., Sarra, M., Fantini, M. C., Rizzo, A., Caruso, R., Caprioli, F., Stolfi, C., Cardolini, I., Dottori, M., Boirivant, M., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.01.041 · Cited by 265
Schmitt, H., Billmeier, U., Dieterich, W., Rath, T., Sonnewald, S., Reid, S., Hirschmann, S., Hildner, K., Waldner, M. J., Mudter, J., et al. (2019) · Gut · doi:10.1136/gutjnl-2017-315671 · Cited by 261
Self-citationSchreiber, S., Aden, K., Bernardes, J. P., Conrad, C., Tran, F., Höper, H., Volk, V., Mishra, N., Blase, J. I., Nikolaus, S., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.02.062 · Cited by 259
Atreya, R., Zimmer, M., Bartsch, B., Waldner, M. J., Atreya, I., Neumann, H., Hildner, K., Hoffman, A., Kiesslich, R., Rink, A. D., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.08.032 · Cited by 256
Self-citationLanger, V., Vivi, E., Regensburger, D., Winkler, T. H., Waldner, M. J., Rath, T., Schmid, B., Skottke, L., Lee, S., Jeon, N. L., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124884 · Cited by 256
Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice
Ito, R., Kita, M., Shin-Ya, M., Kishida, T., Urano, A., Takada, R., Sakagami, J., Imanishi, J., Iwakura, Y., Okanoue, T., et al. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.09.019 · Cited by 251
Anti-commensal IgG Drives Intestinal Inflammation and Type 17 Immunity in Ulcerative Colitis
Castro-Dopico, T., Dennison, T. W., Ferdinand, J. R., Mathews, R. J., Fleming, A., Clift, D., Stewart, B. J., Jing, C., Strongili, K., Labzin, L. I., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.02.006 · Cited by 248
Feagan, B. G., Sands, B. E., Sandborn, W. J., Germinaro, M., Vetter, M., Shao, J., Sheng, S., Johanns, J., Panés, J., Tkachev, A., et al. (2023) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(22)00427-7 · Cited by 245
Fantini, M. C. (2006) · Gut · doi:10.1136/gut.2005.072801 · Cited by 238
Rajca, S., Grondin, V., Louis, E., Vernier-Massouille, G., Grimaud, J.-C., Bouhnik, Y., Laharie, D., Dupas, J.-L., Pillant, H., Picon, L., et al. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000036 · Cited by 236
ILC3 GM-CSF production and mobilisation orchestrate acute intestinal inflammation
Pearson, C., Thornton, E. E., McKenzie, B., Schaupp, A.-L., Huskens, N., Griseri, T., West, N., Tung, S., Seddon, B. P., Uhlig, H. H., et al. (2016) · eLife · doi:10.7554/elife.10066 · Cited by 233
Structure-based decoupling of the pro- and anti-inflammatory functions of interleukin-10
Saxton, R. A., Tsutsumi, N., Su, L. L., Abhiraman, G. C., Mohan, K., Henneberg, L. T., Aduri, N. G., Gati, C., & Garcia, K. C. (2021) · Science · doi:10.1126/science.abc8433 · Cited by 232
Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling
Koelink, P. J., Bloemendaal, F. M., Li, B., Westera, L., Vogels, E. W. M., van Roest, M., Gloudemans, A. K., van 't Wout, A. B., Korf, H., Vermeire, S., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-318264 · Cited by 227
Reinisch, W., de Villiers, W., Bene, L., Simon, L., Rácz, I., Katz, S., Altorjay, I., Feagan, B., Riff, D., Bernstein, C. N., et al. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21038 · Cited by 220
Scheibe, K., Kersten, C., Schmied, A., Vieth, M., Primbs, T., Carlé, B., Knieling, F., Claussen, J., Klimowicz, A. C., Zheng, J., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.11.029 · Cited by 215
Self-citationUnique and redundant functions of NKp46+ ILC3s in models of intestinal inflammation
Song, C., Lee, J. S., Gilfillan, S., Robinette, M. L., Newberry, R. D., Stappenbeck, T. S., Mack, M., Cella, M., & Colonna, M. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20151403 · Cited by 214
IL-23 in inflammatory bowel diseases and colon cancer
Neurath, M. F. (2019) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.12.002 · Cited by 214
Self-citationEngineering cytokine therapeutics
Deckers, J., Anbergen, T., Hokke, A. M., de Dreu, A., Schrijver, D. P., de Bruin, K., Toner, Y. C., Beldman, T. J., Spangler, J. B., de Greef, T. F. A., et al. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00030-y · Cited by 214
Interleukin-35 Mediates Mucosal Immune Responses That Protect Against T-Cell–Dependent Colitis
Wirtz, S., Billmeier, U., Mchedlidze, T., Blumberg, R. S., & Neurath, M. F. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.040 · Cited by 207
Self-citationGuselkumab for the Treatment of Crohn’s Disease: Induction Results From the Phase 2 GALAXI-1 Study
Sandborn, W. J., D’Haens, G. R., Reinisch, W., Panés, J., Chan, D., Gonzalez, S., Weisel, K., Germinaro, M., Frustaci, M. E., Yang, Z., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.01.047 · Cited by 206
Protective mucosal immunity mediated by epithelial CD1d and IL-10
Olszak, T., Neves, J. F., Dowds, C. M., Baker, K., Glickman, J., Davidson, N. O., Lin, C.-S., Jobin, C., Brand, S., Sotlar, K., et al. (2014) · Nature · doi:10.1038/nature13150 · Cited by 203
Macrophage-derived IL-18–mediated intestinal inflammation in the murine model of Crohn's disease
Kanai, T., Watanabe, M., Okazawa, A., Sato, T., Yamazaki, M., Okamoto, S., Ishii, H., Totsuka, T., Iiyama, R., Okamoto, R., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.28021 · Cited by 203
Naganuma, M., Sugimoto, S., Mitsuyama, K., Kobayashi, T., Yoshimura, N., Ohi, H., Tanaka, S., Andoh, A., Ohmiya, N., Saigusa, K., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.11.024 · Cited by 201
Oral Delivery of IL-27 Recombinant Bacteria Attenuates Immune Colitis in Mice
Hanson, M. L., Hixon, J. A., Li, W., Felber, B. K., Anver, M. R., Stewart, C. A., Janelsins, B. M., Datta, S. K., Shen, W., McLean, M. H., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.09.060 · Cited by 195
Role of regulatory T cell in the pathogenesis of inflammatory bowel disease
Yamada, A., Arakaki, R., Saito, M., Tsunematsu, T., Kudo, Y., & Ishimaru, N. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i7.2195 · Cited by 191
Danese, S., Rudziński, J., Brandt, W., Dupas, J., Peyrin‐Biroulet, L., Bouhnik, Y., Kleczkowski, D., Uebel, P., Lukáš, M., Knutsson, M., et al. (2014) · Gut · doi:10.1136/gutjnl-2014-308004 · Cited by 188
Scheibe, K., Backert, I., Wirtz, S., Hueber, A., Schett, G., Vieth, M., Probst, H. C., Bopp, T., Neurath, M. F., & Neufert, C. (2017) · Gut · doi:10.1136/gutjnl-2015-310374 · Cited by 188
Self-citationShouval, D. S., Biswas, A., Kang, Y. H., Griffith, A. E., Konnikova, L., Mascanfroni, I. D., Redhu, N. S., Frei, S. M., Field, M., Doty, A. L., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.08.055 · Cited by 182
Danese, S., Vermeire, S., Hellstern, P., Panaccione, R., Rogler, G., Fraser, G., Kohn, A., Desreumaux, P., Leong, R. W., Comer, G. M., et al. (2019) · Gut · doi:10.1136/gutjnl-2017-314562 · Cited by 181 · cited 1×
“…mIL-6R function) suggested potential efficacy in moderate to severe Crohn’s disease or ulcerative colitis, abscess formation and perforation were detected in some patients upon IL-6 neutralization, potentially due to impaired mIL-6R-dependent proliferation of IECs and altered barrier function 57 .”
Griseri, T., Arnold, I. C., Pearson, C., Krausgruber, T., Schiering, C., Franchini, F., Schulthess, J., McKenzie, B. S., Crocker, P. R., & Powrie, F. (2015) · Immunity · doi:10.1016/j.immuni.2015.07.008 · Cited by 181
IL-9 and its receptor are predominantly involved in the pathogenesis of UC
Nalleweg, N., Chiriac, M. T., Podstawa, E., Lehmann, C., Rau, T. T., Atreya, R., Krauss, E., Hundorfean, G., Fichtner-Feigl, S., Hartmann, A., et al. (2015) · Gut · doi:10.1136/gutjnl-2013-305947 · Cited by 181
Obata, Y., Furusawa, Y., Endo, T. A., Sharif, J., Takahashi, D., Atarashi, K., Nakayama, M., Onawa, S., Fujimura, Y., Takahashi, M., et al. (2014) · Nature Immunology · doi:10.1038/ni.2886 · Cited by 178
Neumann, C., Blume, J., Roy, U., Teh, P. P., Vasanthakumar, A., Beller, A., Liao, Y., Heinrich, F., Arenzana, T. L., Hackney, J. A., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0316-2 · Cited by 177
TGF-β signaling in Th17 cells promotes IL-22 production and colitis-associated colon cancer
Pérez, L. G., Kempski, J., McGee, H. M., Pelczar, P., Agalioti, T., Giannou, A. D., Konczalla, L., Brockmann, L., Wahib, R., Xu, H. Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16363-w · Cited by 172
Repositioning TH cell polarization from single cytokines to complex help
Tuzlak, S., Dejean, A. S., Iannacone, M., Quintana, F. J., Waisman, A., Ginhoux, F., Korn, T., & Becher, B. (2021) · Nature Immunology · doi:10.1038/s41590-021-01009-w · Cited by 171
Tang, C., Kakuta, S., Shimizu, K., Kadoki, M., Kamiya, T., Shimazu, T., Kubo, S., Saijo, S., Ishigame, H., Nakae, S., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0134-y · Cited by 170
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
(2017) · New England Journal of Medicine · doi:10.1056/nejmc1707500 · Cited by 169
Gut CD4+ T cell phenotypes are a continuum molded by microbes, not by TH archetypes
Kiner, E., Willie, E., Vijaykumar, B., Chowdhary, K., Schmutz, H., Chandler, J., Schnell, A., Thakore, P. I., LeGros, G., Mostafavi, S., et al. (2021) · Nature Immunology · doi:10.1038/s41590-020-00836-7 · Cited by 168
Doherty, M. K., Ding, T., Koumpouras, C., Telesco, S. E., Monast, C., Das, A., Brodmerkel, C., & Schloss, P. D. (2018) · mBio · doi:10.1128/mbio.02120-17 · Cited by 165
Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Crohn’s Disease
Sands, B. E., Peyrin‐Biroulet, L., Kierkuś, J., Higgins, P., Fischer, M., Jairath, V., Hirai, F., D’Haens, G., Belin, R. M., Miller, D. L., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.10.050 · Cited by 165
Pavlidis, P., Tsakmaki, A., Pantazi, E. D., Li, K., Cozzetto, D., Digby-Bell, J. L., Yang, F., Lo, J. W., Alberts, E., Costa, A. C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33331-8 · Cited by 165
Wang, Y., Wang, K., Han, G.-C., Wang, R.-X., Xiao, H., Hou, C.-M., Guo, R.-F., Dou, Y., Shen, B.-F., Li, Y., et al. (2014) · Mucosal Immunology · doi:10.1038/mi.2013.126 · Cited by 163
Reinisch, W., Panés, J., Khurana, S., Toth, G., Hua, F., Comer, G. M., Hinz, M., Page, K. M., O’Toole, M., Moorehead, T. M., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-308337 · Cited by 163
Castellanos, J. G., Woo, V., Viladomiu, M., Putzel, G., Lima, S., Diehl, G. E., Marderstein, A. R., Gandara, J., Perez, A. R., Withers, D. R., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.10.014 · Cited by 161
Fichtner–Feigl, S., Young, C. A., Kitani, A., Geissler, E. K., Schlitt, H., & Strober, W. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.08.055 · Cited by 158
Khoryati, L., Pham, M. N., Sherve, M., Kumari, S., Cook, K. D., Pearson, J. T., Bogdani, M., Campbell, D., & Gavin, M. A. (2020) · Science Immunology · doi:10.1126/sciimmunol.aba5264 · Cited by 157
IL-7 receptor influences anti-TNF responsiveness and T cell gut homing in inflammatory bowel disease
Belarif, L., Danger, R., Kermarrec, L., Nerrière‐Daguin, V., Pengam, S., Durand, T., Mary, C., Kerdreux, E., Gauttier, V., Kucik, A., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci121668 · Cited by 146
Involvement of interleukin-21 in the regulation of colitis-associated colon cancer
Stolfi, C., Rizzo, A., Franzè, E., Rotondi, A., Fantini, M. C., Sarra, M., Caruso, R., Monteleone, I., Sileri, P., Franceschilli, L., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20111106 · Cited by 144
Molecular and functional heterogeneity of IL-10-producing CD4+ T cells
Brockmann, L., Soukou, S., Steglich, B., Czarnewski, P., Zhao, L., Wende, S., Bedke, T., Ergen, C., Manthey, C., Agalioti, T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07581-4 · Cited by 144
Cutting Edge: IL-36 Receptor Promotes Resolution of Intestinal Damage
Contreras, O. M., Harusato, A., Nishio, H., Flannigan, K. L., Ngo, V. L., Leoni, G., Neumann, P.-A., Geem, D., Lili, L. N., Ramadas, R. A., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501312 · Cited by 140
IL-36α expression is elevated in ulcerative colitis and promotes colonic inflammation
Russell, S. E., Horan, R. M., Stefanska, A. M., Carey, A., León, G., Aguilera, M., Statovci, D., Moran, T., Fallon, P. G., Shanahan, F., et al. (2016) · Mucosal Immunology · doi:10.1038/mi.2015.134 · Cited by 140
Czarnewski, P., Parigi, S. M., Sorini, C., Diaz, O. E., Das, S., Gagliani, N., & Villablanca, E. J. (2019) · Nature Communications · doi:10.1038/s41467-019-10769-x · Cited by 139
The role of granulocyte macrophage-colony-stimulating factor in acute intestinal inflammation
Xu, Y., Hunt, N. H., & Bao, S. (2008) · Cell Research · doi:10.1038/cr.2008.310 · Cited by 134
Wirtz, S. J., Becker, C., Blumberg, R. S., Galle, P. R., & Neurath, M. F. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.1.411 · Cited by 133
Self-citationGranulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis
Sainathan, S. K., Hanna, E. M., Gong, Q., Bishnupuri, K. S., Luo, Q., Colonna, M., White, F. V., Croze, E., Houchen, C. W., Anant, S., et al. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20279 · Cited by 131
Ngo, V. L., Abo, H., Maxim, E., Harusato, A., Geem, D., Contreras, O. M., Merlin, D., Gewirtz, A. T., Nusrat, A., & Denning, T. L. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718902115 · Cited by 130
Eftychi, C., Schwarzer, R., Vlantis, K., Wachsmuth, L., Basic, M., Wagle, P., Neurath, M. F., Becker, C., Bleich, A., & Pasparakis, M. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.008 · Cited by 129
Self-citationEpithelial expression of interleukin-37b in inflammatory bowel disease
Imaeda, H., Takahashi, K., Fujimoto, T., Kasumi, E., Ban, H., Bamba, S., Sonoda, H., Shimizu, T., Fujiyama, Y., & Andoh, A. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12061 · Cited by 128
IL-27 promotes T cell–dependent colitis through multiple mechanisms
Cox, J. H., Kljavin, N. M., Ramamoorthi, N., Diehl, L. J., Batten, M., & Ghilardi, N. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20100410 · Cited by 127
Rosen, M. J., Frey, M. R., Washington, K. M., Chaturvedi, R., Kuhnhein, L. A., Matta, P., Revetta, F. L., Wilson, K. T., & Polk, D. B. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21628 · Cited by 126
IL-36 in chronic inflammation and fibrosis — bridging the gap?
Elias, M., Zhao, S., Le, H. T., Wang, J., Neurath, M. F., Neufert, C., Fiocchi, C., & Rieder, F. (2021) · Journal of Clinical Investigation · doi:10.1172/jci144336 · Cited by 126
Self-citationAschenbrenner, D., Quaranta, M., Banerjee, S., Ilott, N., Jansen, J., Steere, B., Chen, Y.-H., Ho, S., Cox, K., Arancibia-Cárcamo, C. V., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-321731 · Cited by 123
Nguyen, H. D., Aljamaei, H. M., & Stadnyk, A. W. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.07.005 · Cited by 108
Jacobse, J., Li, J., Rings, E. H. H. M., Samsom, J. N., & Goettel, J. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.716499 · Cited by 108
Voskens, C., Stoica, D., Rosenberg, M., Vitali, F., Zundler, S., Ganslmayer, M., Knott, H., Wiesinger, M., Wunder, J., Kummer, M., et al. (2022) · Gut · doi:10.1136/gutjnl-2022-327075 · Cited by 108
Self-citationGünther, C., Ruder, B., Stolzer, I., Dorner, H., He, G.-W., Chiriac, M. T., Aden, K., Strigli, A., Bittel, M., Zeißig, S., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.07.031 · Cited by 107
Self-citationChiriac, M. T., Buchen, B., Wandersee, A., Hundorfean, G., Günther, C., Bourjau, Y., Doyle, S. E., Frey, B., Ekici, A. B., Büttner, C., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.03.015 · Cited by 105
Self-citationVedolizumab, Adalimumab, and Methotrexate Combination Therapy in Crohn’s Disease (EXPLORER)
Colombel, J., Ungaro, R. C., Sands, B. E., Siegel, C. A., Wolf, D. C., Valentine, J. F., Feagan, B. G., Neustifter, B., Kadali, H., Nazarey, P., et al. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.09.010 · Cited by 105
Verstockt, S., Verstockt, B., Machiels, K., Vancamelbeke, M., Ferrante, M., Cleynen, I., Hertogh, G. D., & Vermeire, S. (2021) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izab032 · Cited by 100
TH17 Cell Induction and Effects of IL-17A and IL-17F Blockade in Experimental Colitis
Schmidt, E. G. W., Larsen, H. L., Kristensen, N. N., Poulsen, S. S., Pedersen, A. M. L., Claësson, M. H., & Pedersen, A. E. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318286fa1c · Cited by 98
Ji, T., Xu, C., Sun, L., Yu, M., Peng, K., Qiu, Y., Xiao, W., & Yang, H. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3632-x · Cited by 93
Gilbert, S., Zhang, R., Denson, L. A., Moriggl, R., Steinbrecher, K. A., Shroyer, N. F., Lin, J., & Han, X. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100192 · Cited by 92
Bernasconi, E., Favre, L., Maillard, M. H., Bachmann, D., Pythoud, C., Bouzourène, H., Croze, E., Velichko, S., Parkinson, J. F., Michetti, P., et al. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21072 · Cited by 91
Herrlinger, K. R., Witthoeft, T., Raedler, A., Bokemeyer, B., Krummenerl, T., Schulzke, J., Boerner, N. H., Kueppers, B., Emmrich, J., Mescheder, A., et al. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.00356.x · Cited by 88
Th17 plasticity and its changes associated with inflammatory bowel disease
Ueno, A., Ghosh, A., Hung, D., Li, J., & Jijon, H. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i43.12283 · Cited by 88
Gibson, D. L., Montero, M., Ropeleski, M. J., Bergstrom, K., Ma, C., Ghosh, S., Merkens, H., Huang, J. T., Månsson, L., Sham, H. P., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.057 · Cited by 86
Jin, S., Chin, J., Seeber, S., et al. (2012) · Mucosal Immunology · doi:10.1038/mi.2012.124 · Cited by 82
Wang, Y., Mao, Y. Q., Zhang, J., Shi, G., Cheng, L., Lin, Y., Li, Y., Zhang, X., Zhang, Y., Chen, X., et al. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13428 · Cited by 80
Apoptotic epithelial cells control the abundance of Treg cells at barrier surfaces
Nakahashi-Oda, C., Udayanga, K. G. S., Nakamura, Y., Nakazawa, Y., Totsuka, N., Miki, H., Iino, S., Tahara‐Hanaoka, S., Honda, S.-I., Shibuya, K., et al. (2016) · Nature Immunology · doi:10.1038/ni.3345 · Cited by 79
Mortha, A., Remark, R., Valle, D. M. D., Chuang, L.-S. F., Chai, Z., Alves, I., Azevedo, C. M., Gaifem, J., Martin, J., Petralia, F., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.05.029 · Cited by 79
Egea, L., McAllister, C. S., Lakhdari, O., Minev, I., Shenouda, S., & Kagnoff, M. F. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202368 · Cited by 78
Sasaoka, T., Ito, M., Yamashita, J., Nakajima, K., Tanaka, I., Narita, M., Hara, Y., Hada, K., Takahashi, M., Ohno, Y., et al. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00329.2010 · Cited by 78
Zhang, Y. S., Xin, D. E., Wang, Z., Song, X., Sun, Y., Zou, Q. C., Yue, J., Zhang, C., Zhang, J. M., Liu, Z., et al. (2019) · The EMBO Journal · doi:10.15252/embj.201899595 · Cited by 78
Vermeire, S., Sands, B. E., Tilg, H., Tulassay, Z., Kempiński, R., Danese, S., Bunganič, I., Nitcheu, J., Santo, J., Scherrer, D., et al. (2022) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(22)00233-3 · Cited by 76
Saxton, R. A., Henneberg, L. T., Calafiore, M., Su, L., Jude, K. M., Hanash, A. M., & García, K. C. (2021) · Immunity · doi:10.1016/j.immuni.2021.03.008 · Cited by 75
Troy, A. E., Zaph, C., Du, Y., Taylor, B. C., Guild, K. J., Hunter, C. A., Saris, C. J. M., & Artis, D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802918 · Cited by 74
Ruiz, D. F. Z., Kim, D. V., Norwood, K., Saldana-Morales, F. B., Kim, M., Ng, C., Callaghan, R., Uddin, M., Chang, L.-C., Longman, R., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2119054 · Cited by 74
The role of ILC2 in pathology of type 2 inflammatory diseases
Bernink, J. H., Germar, K., & Spits, H. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.10.007 · Cited by 73
Wang, Y., Han, G., Wang, K., Liu, G., Wang, R., He, X., Li, X., Hou, C., Shen, B., Guo, R., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1459 · Cited by 72
Perrier, C., Hertogh, G. D., Cremer, J., Vermeire, S., Rutgeerts, P. J., Assche, G. V., Szymkowski, D. E., & Ceuppens, J. L. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.23023 · Cited by 71
Chuang, L.-S. F., Villaverde, N., Hui, K. Y., Mortha, A., Rahman, A. H., Levine, A. P., Haritunians, T., Ng, S. M. E., Zhang, W., Hsu, N.-Y., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.06.045 · Cited by 70
Interleukin-10-based therapy for inflammatory bowel disease
Braat, H., Peppelenbosch, M. P., & Hommes, D. W. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.5.725 · Cited by 66
The Protective Role of Type I Interferons in the Gastrointestinal Tract
Kotredes, K. P., Thomas, B., & Gamero, A. M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00410 · Cited by 66
Gao, H., Cao, M., Yao, Y., Hu, W., Sun, H., Zhang, Y., Zeng, C., Tang, J., Luan, S., & Chen, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.750841 · Cited by 65
Liso, M., Verna, G., Cavalcanti, E., Santis, S. D., Armentano, R., Tafaro, A., Lippolis, A., Campiglia, P., Gasbarrini, A., Mastronardi, M., et al. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.03.003 · Cited by 64
Defective Leukocyte GM-CSF Receptor (CD116) Expression and Function in Inflammatory Bowel Disease
Goldstein, J. I., Kominsky, D. J., Jacobson, N. E., Bowers, B., Regalia, K. A., Austin, G. L., Yousefi, M., Falta, M. T., Fontenot, A. P., Gerich, M. E., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.03.060 · Cited by 63
Lee, C. H., Koh, S., Radi, Z. A., & Habtezion, A. (2023) · Intestinal Research · doi:10.5217/ir.2023.00029 · Cited by 63
Rao, A., Strauss, O., Kokkinou, E., Bruchard, M., Tripathi, K., Schlums, H., Carrasco, A., Mazzurana, L., Kónya, V., Villablanca, E., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15695-x · Cited by 62
IL-23 and IL-2 activation of STAT5 is required for optimal IL-22 production in ILC3s during colitis
Bauché, D., Joyce-Shaikh, B., Fong, J. M., Villarino, A. V., Ku, K. S., JAIN, R. K., Lee, Y., Annamalai, L., Yearley, J. H., & Cua, D. J. (2020) · Science Immunology · doi:10.1126/sciimmunol.aav1080 · Cited by 61
Wang, W., Dong, K., Zhou, L., Jiao, G.-H., Zhu, C., Li, W., Yu, G., Wu, W., Chen, S., Sun, Z., et al. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.51 · Cited by 58
Fonseca‐Camarillo, G., Furuzawa‐Carballeda, J., Llorente, L., & Yamamoto-Furusho, J. K. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9843-4 · Cited by 57
Innate Lymphoid Cells: Regulators of Gut Barrier Function and Immune Homeostasis
Fan, H. J., Wang, A., Wang, Y., Sun, Y., Han, J., Chen, W., Wang, S., Wu, Y., & Lu, Y. (2019) · Journal of Immunology Research · doi:10.1155/2019/2525984 · Cited by 56
Pai, Y.-C., Weng, L.-T., Wei, S., Wu, L., Shih, D. Q., Targan, S. R., Turner, J. R., & Yu, L. C. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa165 · Cited by 56
IL-17A directly inhibits TH1 cells and thereby suppresses development of intestinal inflammation
Awasthi, A., & Kuchroo, V. K. (2009) · Nature Immunology · doi:10.1038/ni0609-568 · Cited by 55
Villarino, A. V., Artis, D., Bezbradica, J. S., Miller, O., Saris, C. J. M., Joyce, S., & Hunter, C. A. (2008) · International Immunology · doi:10.1093/intimm/dxn032 · Cited by 55
Interleukin-38 is elevated in inflammatory bowel diseases and suppresses intestinal inflammation
Xie, C., Yan, W., Quan, R., Chen, C., Tu, L., Hou, X., & Fu, Y. (2020) · Cytokine · doi:10.1016/j.cyto.2019.154963 · Cited by 54
He, Z., Song, J., Hua, J., Yang, M., Ma, Y., Yu, T., Feng, J., Liu, B., Wang, X., Li, Y., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1223-4 · Cited by 53
Atreya, R. N., Peyrin‐Biroulet, L., Klymenko, A. V., Augustyn, M., Бакулин, И. Г., Slankamenac, D., Miheller, P., Gasbarrini, A., Hébuterne, X., Arnesson, K., et al. (2020) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(20)30301-0 · Cited by 53
Self-citationGuo, A., Ross, C., Chande, N., Gregor, J. C., Ponich, T. P., Khanna, R., Sey, M. S. L., Beaton, M. D., Yan, B., Kim, R. B., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-05208-9 · Cited by 53
The genetics of non-monogenic IBD
Jans, D. S., & Cleynen, I. (2023) · Human Genetics · doi:10.1007/s00439-023-02521-9 · Cited by 52
IL-27, targeting antigen-presenting cells, promotes Th17 differentiation and colitis in mice
Visperas, A., Do, J., Bulek, K., Li, X., & Min, B. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.82 · Cited by 51
Nie, M., Huang, D., Chen, G., Zhao, Y., & Sun, L. (2023) · Advanced Science · doi:10.1002/advs.202303349 · Cited by 48
Type I Interferons Control Proliferation and Function of the Intestinal Epithelium
Katlinskaya, Y. V., Katlinski, K. V., Lasri, A., Li, N., Beiting, D. P., Durham, A. C., Yang, T., Pikarsky, E., Lengner, C. J., Johnson, F. B., et al. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00988-15 · Cited by 47
Spondyloarthritis with inflammatory bowel disease: the latest on biologic and targeted therapies
Cozzi, G., Scagnellato, L., Lorenzin, M., Savarino, E. V., Zingone, F., Ometto, F., Favero, M., Doria, A., Vavricka, S. R., & Ramonda, R. (2023) · Nature Reviews Rheumatology · doi:10.1038/s41584-023-00984-8 · Cited by 47
Corazza, N., Brunner, T., Buri, C., Rihs, S., Imboden, M. A., Seibold, I., & Mueller, C. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.06.036 · Cited by 41
Chiabai, M. J., Almeida, J. F., de Azevedo, M. G. D., Fernandes, S. S., Pereira, V. B., de Castro, R. J. A., Jerônimo, M. S., Sousa, I. G., Vianna, L. M. D. S., Miyoshi, A., et al. (2019) · BMC Biotechnology · doi:10.1186/s12896-019-0518-6 · Cited by 41
IL-20 controls resolution of experimental colitis by regulating epithelial IFN/STAT2 signalling
Chiriac, M. T., Hracskó, Z., Günther, C., González-Acera, M., Atreya, R. N., Stolzer, I., Wittner, L., Dressel, A., Schickedanz, L., Gámez‐Belmonte, R., et al. (2023) · Gut · doi:10.1136/gutjnl-2023-329628 · Cited by 41
Self-citationPreventative delivery of IL-35 by Lactococcus lactis ameliorates DSS-induced colitis in mice
Wang, J., Tian, M., Li, W., & Hao, F. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-10094-9 · Cited by 40
Nurbhai, S., Roberts, K. J., Carlton, T. M., Maggiore, L., Cubitt, M. F., Ray, K. P., Reckless, J., Mohammed, H., Irving, P. M., MacDonald, T. T., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-50545-x · Cited by 40
Guimbaud, R., Abitbol, V., Bertrand, V., Quartier, G., Chauvelot‐Moachon, L., Giroud, J., Couturier, D., & Chaussade, D. C. (1998) · PubMed · Cited by 39
Agnholt, J. S., Kelsen, J., Brandsborg, B., Jakobsen, N. O., & Dahlerup, J. F. (2004) · European Journal of Gastroenterology & Hepatology · doi:10.1097/01.meg.0000108344.41221.8b · Cited by 39
Type I interferons for induction of remission in ulcerative colitis
Wang, Y., MacDonald, J. K., Benchimol, E. I., et al. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006790.pub3 · Cited by 39
Direct signaling of TL1A-DR3 on fibroblasts induces intestinal fibrosis in vivo
Jacob, N., Kumagai, K., Abraham, J. P., Shimodaira, Y., Ye, Y., Luu, J., Blackwood, A. Y., Castanon, S. L., Stamps, D. T., Thomas, L. S., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-75168-5 · Cited by 39
Li, J., Ueno, A., Iacucci, M., Gasia, M. F., Jijon, H. B., Panaccione, R., Kaplan, G. G., Beck, P. L., Luider, J. M., Barkema, H. W., et al. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4596-9 · Cited by 38
Roberts, K. J., Cubitt, M. F., Carlton, T. M., Rodrigues-Duarte, L., Maggiore, L., Chai, R., Clare, S., Harcourt, K., MacDonald, T. T., Ray, K. P., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-97236-0 · Cited by 38
TNF hampers intestinal tissue repair in colitis by restricting IL-22 bioavailability
Ninnemann, J., Winsauer, C., Bondareva, M. A., Kühl, A. A., Lozza, L., Durek, P., Lissner, D., Siegmund, B., Kaufmann, S. H. E., Mashreghi, M., et al. (2022) · Mucosal Immunology · doi:10.1038/s41385-022-00506-x · Cited by 38
IFN-γ and IL-17A regulate intestinal crypt production of CXCL10 in the healthy and inflamed colon
Walrath, T., Malizia, R. A., Zhu, X. C., Sharp, S. P., D’Souza, S. S., Lopez‐Soler, R. I., Parr, B. A., Kartchner, B. J., Lee, E. C., Stain, S. C., et al. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00208.2019 · Cited by 37
Zhu, S., Zhang, J., Jiang, X. J., Wang, W., & Chen, Y. Q. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104060 · Cited by 33
Safety and tolerability of spesolimab in patients with ulcerative colitis
Ferrante, M., Irving, P. M., Selinger, C. P., D’Haens, G., Kuehbacher, T., Seidler, U. E., Gropper, S., Haeufel, T., Forgia, S., Danese, S., et al. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2103536 · Cited by 31
Apolit, C., Campos, N., Vautrin, A., Begon‐Pescia, C., Lapasset, L., Scherrer, D., Gineste, P., Ehrlich, H. J., Garcel, A., Santo, J., et al. (2022) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000560 · Cited by 31
Wagner, F., Mansfield, J. C., Lekkerkerker, A., Wang, Y., Keir, M. E., Dash, A., Butcher, B., Harder, B., Orozco, L. D., Mar, J. S., et al. (2023) · Gut · doi:10.1136/gutjnl-2022-328387 · Cited by 31
Bénard, A., Mittelstädt, A., Klösch, B., Glanz, K., Müller, J., Schoen, J., Nüse, B., Brunner, M., Naschberger, E., Stürzl, M., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112637 · Cited by 31
Induction of chronic colitis in IL-10 deficient mice requires IL-4
Specht, S., Arriens, S., & Hoerauf, A. M. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2005.09.006 · Cited by 29
Heß, A., Roesch, J., Saake, M., Sergeeva, M., Hirschmann, S., Neumann, H., Dörfler, A., Neurath, M. F., & Atreya, R. N. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.063 · Cited by 29
Self-citationLow-dose IL-2 shapes a tolerogenic gut microbiota that improves autoimmunity and gut inflammation
Tchitchek, N., Tchoumba, O. F. N., Pires, G., Dandou, S., Campagne, J., Churlaud, G., Fourcade, G., Hoffmann, T. W., Strozzi, F., Gaal, C., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.159406 · Cited by 29
Sands, B. E., Peyrin‐Biroulet, L., Danese, S., Rubin, D. T., Vermeire, S., Laurent, O., Luo, A. Y., Nguyen, D., Lu, J. D., Wiechowska–Kozłowska, A., et al. (2023) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjac190.0040 · Cited by 27
Ullrich, K. A.-M., Derdau, J., Baltes, C., Battistella, A., Rosso, G., Uderhardt, S., Schulze, L. L., Liu, L.-J., Dedden, M., Spocinska, M., et al. (2023) · Gut · doi:10.1136/gutjnl-2023-329818 · Cited by 27
Self-citationInterleukin 11 confers resistance to dextran sulfate sodium-induced colitis in mice
Nishina, T., Deguchi, Y., Kawauchi, M., Xiyu, C., Yamazaki, S., Mikami, T., & Nakano, H. (2023) · iScience · doi:10.1016/j.isci.2023.105934 · Cited by 25
Interleukin 27 is up-regulated in patients with active inflammatory bowel disease
Furuzawa‐Carballeda, J., Fonseca‐Camarillo, G., & Yamamoto-Furusho, J. K. (2016) · Immunologic Research · doi:10.1007/s12026-016-8804-z · Cited by 24
Abo, H., Flannigan, K. L., Geem, D., Ngo, V. L., Harusato, A., & Denning, T. L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00459 · Cited by 24
Interleukin-28A induces epithelial barrier dysfunction in CD patient-derived intestinal organoids
Xu, P., Becker, H. E. F., Elizalde, M., Pierik, M. J., Masclee, A., & Jonkers, D. M. A. E. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00064.2020 · Cited by 24
Oral delivery of a functional algal-expressed TGF-β mimic halts colitis in a murine DSS model
Smyth, D. J., Ren, B., White, M. P. J., McManus, C. M., Webster, H. C., Shek, V., Evans, C. A., Pandhal, J., Fields, F. J., Maizels, R. M., et al. (2021) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2021.08.006 · Cited by 24
Waddell, A., Vallance, J. E., Fox, S. R., & Rosen, M. J. (2021) · Scientific Reports · doi:10.1038/s41598-021-89119-1 · Cited by 23
Interleukin-37 exacerbates experimental colitis in an intestinal microbiome-dependent fashion
Cong, J., Wu, D., Dai, H., Ma, Y., Liao, C., Li, L., Ye, L., & Huang, Z. W. (2022) · Theranostics · doi:10.7150/thno.69616 · Cited by 23
Tachibana, M., Watanabe, N., Koda, Y., Oya, Y., Kaminuma, O., Katayama, K., Fan, Z., Sakurai, F., Kawabata, K., Hiroi, T., et al. (2019) · International Immunology · doi:10.1093/intimm/dxz076 · Cited by 22
TL1A as a therapeutic target in inflammatory bowel disease
Kokkotis, G., & Bamias, G. (2022) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2022.2074401 · Cited by 21
Cited by
The intestinal barrier: a pivotal role in health, inflammation, and cancer
Neurath, M. F., Artis, D., & Becker, C. (2025) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(24)00390-x · Cited by 487
Self-citation
Metadata
- Authors
- Neurath, M. F.
- Venue
- Nature Reviews Immunology
- Published
- 2024-03-14
- Volume
- 24
- Issue
- 8
- Pages
- 559-576
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W4392797782
- Cited by
- 398
- References
- 211
- FWCI
- 37.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.